Immunotherapy shows promising results in targeting deadliest brain cancer

Yasmin Sheikh, head of policy and public affairs at Anthony Nolan, said: “At Anthony Nolan, we’ve seen first-hand how transformative CAR T-cell therapy can be for people with blood cancer.

“This research is an exciting step forward and adds to growing evidence that CAR T-cell therapy could also offer new hope for people living with other forms of cancer, including brain cancer.

“While these findings are highly encouraging for the future, we also need to be thinking about how innovative treatments like this one can be delivered in practice.

“The NHS must ensure that it has the workforce and infrastructure in place so that patients can benefit from new therapies without delay.”